A. Tamori

A. Tamori, N. Kawada, J. Kawabe, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.

A. Tamori, S. Kubo, Y. Yano, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C

A. Tamori, A. Hagihara, N. Kawada, 2018, United European gastroenterology journal.

Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma.

A. Tamori, S. Kubo, T. Uenishi, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

Previous or Occult Hepatitis B Virus Infection in Hepatitis C Virus-Associated Hepatocellular Carcinoma Without Hepatic Fibrosis

A. Tamori, K. Wakasa, H. Kinoshita, 2001, Digestive Diseases and Sciences.

Multicentric occurrence of hepatocellular carcinoma in patients with a somatic mutation of mitochondorial DNA and hepatitis C virus.

A. Tamori, H. Kinoshita, S. Kubo, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma.

A. Tamori, H. Kinoshita, S. Kubo, 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

Sequencing of human‐viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection

A. Tamori, H. Kinoshita, S. Kubo, 2003, Journal of medical virology.

Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West

A. Tamori, Etsuko Iio, Yasuhito Tanaka, 2020 .

Clinical significance of pretreatment serum interferon‐gamma‐inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir‐based triple therapy

A. Tamori, N. Kawada, Y. Osaki, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor‐naïve patients with chronic HCV genotype 1b infection in a real‐world cohort

A. Tamori, A. Hagihara, N. Kawada, 2018, Journal of viral hepatitis.

Randomized trial of combined triple therapy comprising two types of peginterferon with simeprevir in patients with hepatitis C virus genotype 1b

A. Tamori, A. Hagihara, N. Kawada, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Recent Advances in Antiviral Therapy for Chronic Hepatitis C

A. Tamori, N. Kawada, M. Enomoto, 2016, Mediators of inflammation.

Interferon‐α/β for treatment of chronic hepatitis C infection in the era of direct‐acting antiviral agents

A. Tamori, N. Kawada, Y. Murakami, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug use

A. Tamori, A. Hagihara, N. Kawada, 2020, JGH open : an open access journal of gastroenterology and hepatology.

Post-Treatment M2BPGi Level and the Rate of Autotaxin Reduction are Predictive of Hepatocellular Carcinoma Development after Antiviral Therapy in Patients with Chronic Hepatitis C

A. Tamori, M. Hino, N. Kawada, 2020, International journal of molecular sciences.

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication.

H. Nomura, J. Hayashi, Hwai I. Yang, 2019, Clinical Infectious Diseases.

Cyclical etidronate for treatment of osteopenia in patients with cirrhosis of the liver.

A. Tamori, S. Nishiguchi, S. Shiomi, 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway.

A. Tamori, K. Yoshizato, S. Kubo, 2015, The American journal of pathology.

Clinical need for both scintigraphy with technetium-99m GSA and per-rectal portal scintigraphy in some patients with chronic liver disease

A. Tamori, T. Kuroki, S. Nishiguchi, 1999, Annals of nuclear medicine.

Influenza A(H1N1)pdm09 vaccine effectiveness and other characteristics associated with hospitalization in chronic liver disease patients

A. Tamori, Y. Hirota, S. Ohfuji, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Immunogenicity of influenza A(H1N1)pdm09 vaccine and the associated factors on lowered immune response in patients with hepatitis C

A. Tamori, Y. Hirota, S. Ohfuji, 2012, Influenza and other respiratory viruses.

Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus

A. Tamori, S. Kubo, Hiromu Tanaka, 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

Effect of Long-Term Postoperative Interferon Therapy on Intrahepatic Recurrence and Survival Rate after Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma

A. Tamori, S. Kubo, S. Nishiguchi, 2005, Intervirology.

Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver

A. Tamori, S. Kubo, S. Nishiguchi, 2002, American Journal of Gastroenterology.

Effects of Long-Term Postoperative Interferon- Therapy on Intrahepatic Recurrence after Resection of Hepatitis C VirusRelated Hepatocellular Carcinoma

A. Tamori, H. Kinoshita, S. Kubo, 2001, Annals of Internal Medicine.

Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in japanese patients with hepatitis C virus

A. Tamori, H. Kinoshita, S. Kubo, 1999, Hepatology.

A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C

A. Tamori, K. Matsuura, Y. Takei, 2021, PloS one.

Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis

A. Tamori, N. Kawada, H. Fujii, 2009, Journal of Gastroenterology.

Association of serum autotaxin levels with liver fibrosis in patients pretreatment and posttreatment with chronic hepatitis C

A. Tamori, M. Hino, N. Kawada, 2020, Journal of gastroenterology and hepatology.

Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication

A. Tamori, A. Hagihara, S. Kubo, 2018, PloS one.

Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver

A. Tamori, A. Hagihara, K. Yoshizato, 2014, Laboratory Investigation.

Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C

H. Nomura, H. Yoshiji, N. Enomoto, 2014, Human Genetics.

Response-Guided Peginterferon α-2a Monotherapy for Hemodialysis Patients with Chronic Hepatitis C

A. Tamori, N. Kawada, T. Yamakawa, 2014 .

Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.

A. Tamori, A. Hagihara, N. Kawada, 2020, Annals of hepatology.

CASE REPORT: Esophagogastric Varices Due to Arterioportal Shunt in a Serous Cystadenoma of the Pancreas in von Hippel-Lindau Disease

A. Tamori, K. Wakasa, T. Shuin, 2003, Digestive Diseases and Sciences.

Interferon reduces somatic mutation of mitochondrial DNA in liver tissues from chronic viral hepatitis patients

A. Tamori, S. Nishiguchi, M. Nishikawa, 2005, Journal of viral hepatitis.

Fewer Somatic Mutations of Mitochondrial DNA in Noncancerous Liver Tissue of Patients with Hepatocellular Carcinoma Respond to Interferon Therapy

A. Tamori, H. Kinoshita, S. Kubo, 2003 .

Disease associations and altered immune function in CD45 138G variant carriers.

W. Bodmer, A. Tamori, O. Ishiko, 2004, Human molecular genetics.

Risk factors for hepatocellular carcinoma in treated chronic hepatitis C patients–Relationship to smoking and alcohol

A. Tamori, S. Kubo, N. Kawada, 2020, JGH open : an open access journal of gastroenterology and hepatology.

Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients.

A. Tamori, Mitsuo Takahashi, Y. Takahara, 2008, World journal of gastroenterology.

Randomized Trial Assessing Gastric Emptying in Patients with Chronic Hepatitis C During Interferon-α or -β Therapy and Effect of Cisapride

A. Tamori, J. Kawabe, S. Nishiguchi, 2004, Digestive Diseases and Sciences.

Does a late evening meal reduce the risk of hepatocellular carcinoma among patients with chronic hepatitis C?

A. Tamori, S. Seki, N. Kawada, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

GASTROINTESTINAL , HEPATOBILIARY , AND PANCREATIC PATHOLOGY Cytoglobin De fi ciency Promotes Liver Cancer Development from Hepatosteatosis through Activation of the Oxidative Stress Pathway

A. Tamori, K. Yoshizato, S. Kubo, 2022 .

Identification of genes differentially expressed by putrescine in HepG2 hepatoblastoma cells.

A. Tamori, Y. Yano, S. Otani, 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

Severely reduced production of klotho in human chronic renal failure kidney.

A. Tamori, T. Kuroki, K. Sugimura, 2001, Biochemical and biophysical research communications.

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.

A. Tamori, T. Kuroki, K. Hirohashi, 2001, Annals of internal medicine.

Thiopurine S‐methyltransferase gene polymorphism in Japanese patients with autoimmune liver diseases

A. Tamori, M. Hino, N. Kawada, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Successful treatment of giant rectal varices by modified percutaneous transhepatic obliteration with sclerosant: Report of a case.

A. Tamori, K. Tominaga, Toshio Watanabe, 2006, World journal of gastroenterology.

Effects of ribavirin combined with interferon‐α2b on viral kinetics during first 12 weeks of treatment in patients with hepatitis C virus genotype 1 and high baseline viral loads

A. Tamori, S. Seki, S. Nishiguchi, 2004, Journal of viral hepatitis.

Dynamics of hepatitis C virus monitored by real-time quantitative polymerase chain reaction during first 2 weeks of IFN-beta treatment are predictive of long-term therapeutic response.

A. Tamori, Y. Yano, S. Otani, 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Cancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms

A. Tamori, K. Yoshizato, S. Kubo, 2022, Science advances.

Relationship between inosine triphosphate genotype and outcome of extended therapy in hepatitis C virus patients with a late viral response to pegylated‐interferon and ribavirin

A. Tamori, A. Hagihara, Yasuhito Tanaka, 2014, Journal of gastroenterology and hepatology.

Response‐guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2

A. Tamori, A. Hagihara, Yasuhito Tanaka, 2012, Hepatology Research.

Association of IL28B variants with response to pegylated‐interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b

M. Kurosaki, A. Tamori, S. Kakinuma, 2011, Journal of medical virology.

Interferon-β plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial

T. Saibara, A. Tamori, S. Onishi, 2005, Gut.

Alcohol abuse as an etiologic factor for hepatocellular carcinoma in Japan.

A. Tamori, S. Kubo, K. Hirohashi, 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

Case of small hepatocellular carcinoma in the caudate lobe detected after interferon caused disappearance of hepatitis C virus.

A. Tamori, T. Kuroki, M. Morimoto, 1996, Hepato-gastroenterology.

Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma

A. Tamori, A. Hagihara, S. Kubo, 2022, JGH open : an open access journal of gastroenterology and hepatology.

Effect of Caffeine-Containing Beverage Consumption on Serum Alanine Aminotransferase Levels in Patients with Chronic Hepatitis C Virus Infection: A Hospital-Based Cohort Study

A. Tamori, N. Kawada, Y. Hirota, 2013, PloS one.

Destructive thyroiditis presenting as thyrotoxicosis followed by hypothyroidism during lenvatinib therapy for hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2020, Clinical Journal of Gastroenterology.

Switching to tenofovir disoproxil fumarate vs continuing treatment in patients with chronic hepatitis B who maintain long‐term virological response to entecavir therapy: A randomized trial

A. Tamori, N. Kawada, M. Enomoto, 2019, Journal of medical virology.

Association between HLA‐DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment

A. Tamori, A. Hagihara, N. Kawada, 2018, Journal of gastroenterology and hepatology.

Sequential therapy involving an early switch from entecavir to pegylated interferon‐α in Japanese patients with chronic hepatitis B

A. Tamori, K. Higuchi, N. Kawada, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial.

A. Tamori, S. Nishiguchi, Takashi Tanaka, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Pancreatic Cancer Cell Fraction Estimation in a DNA Sample

A. Tamori, T. Ushijima, A. Hagihara, 2018, Oncology.

Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection

A. Tamori, S. Kubo, N. Kawada, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B

A. Tamori, H. Imanishi, N. Kawada, 2013, Journal of Gastroenterology.

Clinical role of FDG-PET for HCC: relationship of glucose metabolic indicator to Japan Integrated Staging (JIS) score.

A. Tamori, N. Kawada, J. Kawabe, 2008, Hepato-gastroenterology.

Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis.

A. Tamori, M. Ishii, N. Kawada, 2008, Annals of internal medicine.

A 56 Year‐Old Female with Congenital Hepatic Fibrosis Diagnosed by Laparoscopy

A. Tamori, S. Seki, T. Kuroki, 1999 .

Randomized pilot trial of vitamin K2 for bone loss in patients with primary biliary cirrhosis.

A. Tamori, S. Kubo, S. Nishiguchi, 2001, Journal of hepatology.

TT virus infection in patients with chronic liver disease of unknown etiology

A. Tamori, S. Seki, Y. Yano, 2000, Journal of medical virology.

Title Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma

K. Iwaisako, T. Ochiya, A. Tamori, 2018 .

Direct‐acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment

A. Tamori, A. Hagihara, N. Kawada, 2021, Journal of viral hepatitis.

The Administration of Tenofovir Disoproxil Fumarate for Pregnant Japanese Women with Chronic Hepatitis B

A. Tamori, N. Kawada, M. Enomoto, 2020, Internal medicine.

Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus

A. Tamori, S. Kubo, N. Kawada, 2009, Journal of medical virology.

Previous or Occult Hepatitis B Virus Infection in Hepatitis B Surface Antigen-Negative and Anti-Hepatitis C-Negative Patients with Hepatocellular Carcinoma

A. Tamori, H. Kinoshita, S. Kubo, 2004, Surgery Today.

Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West

A. Tamori, Etsuko Iio, Yasuhito Tanaka, 2020, Hepatology.

Point mutation of ornithine decarboxylase gene in human hepatocellular carcinoma.

A. Tamori, Y. Yano, S. Otani, 1995, Cancer research.

Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential

A. Tamori, N. Kawada, S. Nishiguchi, 2013, Journal of Gastroenterology.

Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy

A. Tamori, N. Kawada, S. Nishiguchi, 2021, International journal of molecular sciences.

Promotion of intra-hospital referral of hepatitis B and C virus carriers to hepatology specialists by electronic medical record-based alert system: a case study at a university hospital

A. Tamori, A. Hagihara, N. Kawada, 2016 .

Development of novel hepatitis B virus capsid inhibitor using in silico screening.

A. Tamori, Y. Yano, N. Kawada, 2015, Biochemical and biophysical research communications.

Hepatitis C virus recurrence in two patients who achieved sustained viral response with interferon-free direct-acting antiviral therapy: reinfection or relapse?

A. Tamori, Etsuko Iio, Yasuhito Tanaka, 2019, Clinical Journal of Gastroenterology.

Prospective study of α‐fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

Kenzo Kobayashi, A. Tamori, T. Kuroki, 1994 .

GB virus C and TT virus infections in Japanese patients with autoimmune hepatitis

A. Tamori, Y. Yano, S. Otani, 2002, Journal of medical virology.

Role of hepatitis B virus DNA integration in human hepatocarcinogenesis.

Hoang Hai, A. Tamori, N. Kawada, 2014, World journal of gastroenterology.

A case of primary small cell carcinoma of the liver that was treated with chemotherapy

A. Tamori, S. Kudoh, N. Oshitani, 2008, Hepatology international.

Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma

M. Honda, M. Yuen, W. Seto, 2018, Scientific Reports.

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.

A. Tamori, T. Kuroki, T Kuroki, 1994, Hepatology.

Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment: comparison with three other assays.

A. Tamori, S. Seki, T. Arakawa, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug‐resistant variants during lamivudine therapy: Analyses of the polymerase gene and full‐length sequences

A. Tamori, S. Seki, N. Kawada, 2007, Journal of medical virology.

[Sequential therapy with a nucleos(t)ide analogue and interferon in patients with chronic hepatitis B: efficacy and limitations].

A. Tamori, N. Kawada, S. Nishiguchi, 2011, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean

A. Koike, T. Ide, M. Honda, 2012, PloS one.

Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy

A. Tamori, N. Kawada, Tomohiro Ogawa, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Lamivudine and IFN-beta sequential therapy in HBe antigen-positive patients with chronic hepatitis B virus genotype C infection.

A. Tamori, S. Seki, N. Kawada, 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers

A. Tamori, S. Seki, N. Kawada, 2005, Journal of medical virology.

Hepatitis B virus genotypes and response to antiviral therapy.

A. Tamori, S. Nishiguchi, M. Enomoto, 2006, Clinical laboratory.

Add‐on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine‐refractory hepatitis B virus

A. Tamori, N. Kawada, Y. Imanishi, 2010, Journal of viral hepatitis.

A pregnant woman with acute hepatitis B in whom vertical transmission was prevented by tenofovir disoproxil fumarate

A. Tamori, N. Kawada, M. Enomoto, 2013, Clinical Journal of Gastroenterology.

Anti‐hepatitis B virus therapy: To stop, or not to stop: Has the question been solved?

A. Tamori, N. Kawada, M. Enomoto, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg‐negative chronic hepatitis B: a randomized trial

A. Tamori, N. Kawada, S. Nishiguchi, 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

Alteration of Gene Expression in Human Hepatocellular Carcinoma with Integrated Hepatitis B Virus DNA

M. Kanehisa, Yoshihiro Yamanishi, A. Tamori, 2005, Clinical Cancer Research.

TRANSFUSION-TRANSMITTED HBV INFECTION DETECTED BY LOOKBACK STUDY FOR BLOOD DONOR-A CASE REPORT

A. Tamori, M. Hino, N. Kawada, 2008 .

Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection.

A. Tamori, N. Kawada, Y. Murakami, 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia

T. Ide, M. Honda, S. Kaneko, 2014, PloS one.

Discovering novel direct acting antiviral agents for HBV using in silico screening.

A. Tamori, Y. Yano, N. Kawada, 2015, Biochemical and biophysical research communications.

Novel monitoring of hepatitis B reactivation based on ultra‐high sensitive hepatitis B surface antigen assay

A. Tamori, S. Iida, Yasuhito Tanaka, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

M. Kudo, N. Hayashi, N. Hiramatsu, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?

A. Tamori, S. Nishiguchi, K. Shiraki, 2001, Journal of Gastroenterology.

Hepatitis B virus infection and alcohol consumption

A. Tamori, N. Kawada, M. Enomoto, 2017, World journal of gastroenterology.

High prevalence of hepatitis C virus infection in Airin district, Osaka, Japan: A hospital‐based study of 1162 patients

A. Tamori, Y. Fujiwara, T. Arakawa, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Hepatitis B-associated cryoglobulinemia and antiphospholipid antibodies

A. Tamori, N. Kawada, H. Fujii, 2010 .

HLA class II associated with outcomes of hepatitis B and C infections.

A. Tamori, N. Kawada, 2013, World journal of gastroenterology.

Effects on anemia of drug adjustment in patients with chronic hepatitis C during telaprevir-combined therapy.

A. Tamori, A. Hagihara, N. Kawada, 2015, Annals of hepatology.

MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy

A. Tamori, S. Kubo, N. Kawada, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2018, Cancer Chemotherapy and Pharmacology.

Circulating Exosomal miRNA Profiles Predict the Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with Direct-Acting Antiviral-Induced Sustained Viral Response

T. Akutsu, T. Ochiya, A. Tamori, 2019, Biomedicines.

Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma

T. Utsunomiya, T. Ochiya, A. Tamori, 2016, Molecular Cancer.

Comparison of Hepatocellular Carcinoma miRNA Expression Profiling as Evaluated by Next Generation Sequencing and Microarray

Yoshiki Murakami, Takeshi Azuma, Takashi Kumada, 2014, PloS one.

Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC

A. Tamori, K. Wakasa, S. Kubo, 2008, International Journal of Clinical Oncology.

Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization

A. Tamori, A. Hagihara, N. Kawada, 2020, Cancers.

HOXA5 Regulates Expression of the Progesterone Receptor*

S. Sukumar, K. Zeller, V. Raman, 2000, The Journal of Biological Chemistry.

Per‐rectal portal scintigraphy as an alternative measure of hepatic venous pressure gradient in chronic liver disease: A preliminary report

A. Yamamoto, A. Tamori, N. Kawada, 2021, Clinical physiology and functional imaging.

Assessment of hepatic blood flow by PET with 15O water: Correlation between per-rectal portal scintigraphy with 99Tcm-pertechnetate and scintigraphy with 99Tcm-GSA

A. Tamori, T. Kuroki, S. Nishiguchi, 2000, Nuclear medicine communications.

A case of hepatocellular carcinoma with “pseudoprogression” followed by complete response to atezolizumab plus bevacizumab

A. Tamori, A. Hagihara, N. Kawada, 2023, Clinical Journal of Gastroenterology.

Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma

A. Tamori, A. Hagihara, Y. Fujiwara, 2020, Internal medicine.

Intention‐to‐treat assessment of glecaprevir + pibrentasvir combination therapy for patients with chronic hepatitis C in the real world

A. Tamori, K. Nouso, N. Kawada, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Comparison of real‐time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus

A. Tamori, Y. Yano, S. Nishiguchi, 2001, Journal of gastroenterology and hepatology.

Accessory spleen in the pelvis diagnosed by Tc-99m phytate scintigraphy

A. Tamori, J. Kawabe, S. Nishiguchi, 2001, Annals of nuclear medicine.

Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus

A. Tamori, N. Kawada, H. Kumada, 2018, Clinical Journal of Gastroenterology.

Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.

H. Yoshiji, K. Ikeo, N. Enomoto, 2017, Gastroenterology.

Development of Pouchitis With Combination Therapy With Peg-Interferon α-2b and Ribavirin for Chronic Hepatitis C in a Patient With Ulcerative Colitis Who Underwent Pouch Surgery

A. Tamori, K. Tominaga, Toshio Watanabe, 2009, The American Journal of Gastroenterology.

Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis

T. Ide, M. Honda, M. Kurosaki, 2016, Scientific Reports.

Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis

A. Tamori, A. Hagihara, N. Kawada, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

PTPRC (CD45) variation and disease association studied using single nucleotide polymorphism tagging.

A. Hill, W. Bodmer, A. Tamori, 2008, Tissue Antigens.

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis.

F. Zoulim, T. Ide, J. Dufour, 2019, Journal of hepatology.

Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis

A. Tamori, A. Hagihara, N. Kawada, 2023, Journal of Gastroenterology.

Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination.

A. Tamori, A. Hagihara, N. Kawada, 2017, Annals of hepatology.

Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis

A. Tamori, S. Nishiguchi, Takashi Tanaka, 2001, The Lancet.

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

K. Chayama, M. Kurosaki, M. Sakamoto, 2018, Journal of Gastroenterology.

HBV DNA integration and HBV‐transcript expression in non‐B, non‐C hepatocellular carcinoma in Japan

A. Tamori, S. Kubo, K. Hirohashi, 2003, Journal of medical virology.

Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed

A. Tamori, A. Hagihara, N. Kawada, 2017, International journal of molecular sciences.

A case of hepatitis C virus-associated mixed cryoglobulinemic vasculitis treated with daclatasvir and asunaprevir

A. Tamori, A. Hagihara, N. Kawada, 2016 .

Expression of Connective Tissue Growth Factor in the Human Liver with Idiopathic Portal Hypertension

A. Tamori, N. Kawada, S. Nishiguchi, 2007, Molecular medicine.

Could Trastuzumab Suppress Hepatitis C Virus in a Patient With Chronic Hepatitis and Breast Cancer?

A. Tamori, N. Kawada, K. Hirakawa, 2011, The American Journal of Gastroenterology.

Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.

A. Tamori, S. Kubo, S. Nishiguchi, 2004, JAMA.

Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein

A. Yamamoto, Y. Miki, A. Tamori, 2020, Gut.

A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET

A. Tamori, N. Kawada, S. Higashiyama, 2007, Annals of nuclear medicine.

Highly Sensitive Circulating MicroRNA Panel for Accurate Detection of Hepatocellular Carcinoma in Patients With Liver Disease

T. Ochiya, A. Tamori, H. Sakamoto, 2019, Hepatology communications.

Comprehensive analysis of liver and blood miRNA in precancerous conditions

K. Tsuneyama, A. Tamori, M. Kawano, 2020, Scientific Reports.

The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis

A. Tamori, S. Kubo, M. Kuroda, 2013, BMC Cancer.

Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma.

A. Tamori, H. Kinoshita, S. Kubo, 2001, Cancer research.

Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2017, Scientific Reports.

Genome-Wide Association Study Identi fi es TLL 1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection

H. Yoshiji, K. Ikeo, N. Enomoto, 2017 .

Successful Treatment of Hepatitis B Virus‐associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents

A. Tamori, M. Inaba, E. Ishimura, 2014, Nephrology.

Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation

A. Tamori, K. Matsuura, S. Yagi, 2022, Journal of Gastroenterology.

LAPAROSCOPIC WEDGE BIOPSY OF THE LIVER WITH USE OF AN ULTRASONICALLY ACTIVATED SCALPEL

A. Tamori, S. Seki, S. Nishiguchi, 2001 .

Effect of Mosapride Citrate on Gastric Emptying in Interferon-Induced Gastroparesis

A. Tamori, A. Hagihara, K. Tominaga, 2012, Digestive Diseases and Sciences.

Soluble programmed cell death-1 predicts hepatocellular carcinoma development during nucleoside analogue treatment

A. Tamori, A. Hagihara, N. Kawada, 2021, Scientific reports.

Implications of hyperechoic lesions in small hepatocellular carcinoma

A. Tamori, T. Kuroki, Sei-Joong Kim, 1989, Gastroenterologia Japonica.

Effect of ethanol on bone mineral density of rats evaluated by dual-photon X-ray absorptiometry

A. Tamori, S. Nishiguchi, Takashi Tanaka, 2000, Journal of Bone and Mineral Metabolism.

Nutritional status in relation to lifestyle in patients with compensated viral cirrhosis.

A. Tamori, A. Hagihara, N. Kawada, 2012, World journal of gastroenterology.

Vitamins In Hepatocellular Carcinoma

A. Tamori, S. Shiomi, 2009 .

A case of hepatocellular carcinoma successfully treated by percutaneous radiofrequency ablation using the laparoscopic artificial ascites technique

A. Tamori, S. Seki, N. Kawada, 2007 .

Efficacy of laparoscopic microwave coagulation therapy for hepatocellular carcinoma Comparison of survival rates between laparoscopic microwave coagulation therapy and percutaneous ethanol injection therapy

A. Tamori, S. Seki, S. Nishiguchi, 2002 .

Study for recurrences of hepatocellular carcinoma after laparoscopic microwave coagulation therapy

A. Tamori, S. Seki, S. Nishiguchi, 2001 .

[Drug-induced liver injury caused by an herbal medicine, bofu-tsu-sho-san].

A. Tamori, N. Kawada, H. Fujii, 2008, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Usefulness of scintigraphy with technetium-99m galactosyl human serum albumin in prediction of prognosis of primary biliary cirrhosis.

A. Tamori, J. Kawabe, S. Nishiguchi, 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2020, Scientific Reports.

Esophagogastric varices due to arterioportal shunt in a serous cystadenoma of the pancreas in von Hippel-Lindau disease.

A. Tamori, K. Wakasa, T. Shuin, 2003, Digestive diseases and sciences.

Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.

A. Tamori, A. Hagihara, N. Kawada, 2020, The American journal of gastroenterology.

Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon‐α2b and ribavirin therapy in patients with genotype 1 and high viral loads

A. Tamori, S. Seki, N. Kawada, 2005, Journal of medical virology.

The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases

S. Fukumoto, A. Tamori, Tatsuo Kimura, 2021, Scientific Reports.

Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines

A. Tamori, O. Yokosuka, Y. Takikawa, 2021, Scientific Reports.

Outcome of nucleos(t)ide analog intervention in patients with preventive or on‐demand therapy for hepatitis B virus reactivation

A. Tamori, M. Mizokami, N. Kawada, 2020, Journal of medical virology.

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

H. Nomura, J. Hayashi, Hwai I. Yang, 2019, Hepatology International.

Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas

A. Yamamoto, Y. Miki, A. Tamori, 2020, Oncology.

Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection: decision-tree analysis

M. Kurosaki, N. Hiramatsu, M. Sakamoto, 2011, Journal of Gastroenterology.

Postoperative direct‐acting antiviral treatment after liver resection in patients with hepatitis C virus‐related hepatocellular carcinoma

A. Tamori, S. Kubo, N. Kawada, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

A case of autoimmune hepatitis showing resistance to a steroid and immunosuppressants

A. Tamori, N. Kawada, H. Fujii, 2009 .

Use of Interferon-α for Prevention of Hepatocellular Carcinoma in Patients with Chronic Active Hepatitis C with Cirrhosis

A. Tamori, S. Seki, T. Kuroki, 1999 .

CASE REPORT: Asymptomatic Chronic Intestinal Ischemia Caused by Idiopathic Phlebosclerosis of Mesenteric Vein

A. Tamori, S. Seki, N. Oshitani, 2002, Digestive Diseases and Sciences.

Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma

A. Tamori, S. Kubo, S. Nishiguchi, 2001, American Journal of Gastroenterology.

Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy

A. Tamori, A. Hagihara, N. Kawada, 2017, Journal of gastroenterology and hepatology.

Soluble immune checkpoint protein CD27 is a novel prognostic biomarker of HCC development in HCV-SVR patients.

A. Tamori, N. Kawada, M. Enomoto, 2022, The American journal of pathology.

Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2020, Scientific Reports.

Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C

H. Nomura, H. Yoshiji, K. Ikeo, 2016, PloS one.

Sequences in the interferon sensitivity‐determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG‐interferon plus ribavirin: Data mining analysis

M. Kurosaki, N. Hiramatsu, M. Sakamoto, 2011, Journal of medical virology.

Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.

A. Tamori, S. Seki, N. Kawada, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination.

A. Tamori, A. Hagihara, N. Kawada, 2017, Annals of hepatology.

Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis

S. Fukumoto, A. Tamori, A. Hagihara, 2021, JGH open : an open access journal of gastroenterology and hepatology.

Risk factors for liver‐related and non‐liver‐related mortality following a sustained virological response after direct‐acting antiviral treatment for hepatitis C virus infection in a real‐world cohort

A. Tamori, A. Hagihara, N. Kawada, 2022, Journal of Viral Hepatitis.

Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct‐acting antivirals

A. Tamori, S. Kubo, N. Kawada, 2020, Journal of surgical oncology.

Investigation of interferon-α response by a single amino acid substitution of nonstructural protein 5A in hepatitis C virus-infected patients.

A. Tamori, S. Ikeda, S. Nishiguchi, 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study.

A. Tamori, S. Seki, N. Kawada, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

Changes in hypervariable region 1 in patients with chronic hepatitis C of genotype 1b with biochemical response to interferon.

N. Tatsumi, A. Tamori, S. Otani, 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

TRENDS IN THE CAUSES AND OUTCOME OF LIVER CIRRHOSIS DIAGNOSED BY LAPAROSCOPY IN OSAKA, JAPAN DURING THE PAST THREE DECADES

A. Tamori, S. Seki, T. Kuroki, 2001 .

Lamivudine therapy for hepatitis B virus reactivation in a patient receiving intra-arterial chemotherapy for advanced hepatocellular carcinoma.

A. Tamori, S. Nishiguchi, Kenji Nakamura, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

ACASE OF SECONDARY AMYL OIDOSIS ACCOMPANYING ILEAL ULCERS

A. Tamori, N. Oshitani, T. Arakawa, 1995 .

Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.

A. Tamori, N. Kawada, M. Enomoto, 2014, World journal of gastroenterology.

Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma

T. Utsunomiya, T. Ochiya, M. Nojima, 2016, Molecular Cancer.

Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma

A. Tamori, S. Kubo, M. Inoue, 2004, Journal of Gastroenterology.

Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C

H. Nomura, H. Yoshiji, N. Enomoto, 2015, Human Genetics.

Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection?

A. Tamori, S. Seki, N. Kawada, 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non‐alcoholic fatty liver disease

A. Tamori, N. Kawada, Tomohiro Ogawa, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C

Hiroyasu Morikawa, Hideki Fujii, A. Tamori, 2011, Journal of Gastroenterology.

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

H. Nomura, J. Hayashi, Hwai I. Yang, 2020, Hepatology International.

Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma.

A. Tamori, Hayato Nakagawa, Y. Suehiro, 2023, Hepatology international.

Portal vein thrombosis following percutaneous ethanol injection therapy for hepatocellular carcinoma.

A. Tamori, S. Seki, S. Nishiguchi, 2002, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study.

M. Buti, Rui Huang, Chao Wu, 2023, Hepatology international.

[Epidemiology of HBV related hepatocellular carcinoma in Japan].

A. Tamori, S. Nishiguchi, Takashi Tanaka, 2004, Nihon rinsho. Japanese journal of clinical medicine.

Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization

A. Tamori, N. Kawada, M. Enomoto, 2009, Hepatology international.

Positioning of 18F‐fluorodeoxyglucose‐positron emission tomography imaging in the management algorithm of hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2014, Journal of gastroenterology and hepatology.

Artificial pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2011 .

Alternative methods of radiofrequencty ablation for hepatocellular carcinoma located close to the hepatic dome

A. Tamori, N. Kawada, H. Fujii, 2008 .

Development of Hepatocelluar Carcinoma in Patients with HCV Infection, with or without Past HBV Infection, and Relationship to age at the Time of Transfusion

A. Tamori, H. Kinoshita, S. Kubo, 1998, Vox sanguinis.

Resected cases of hepatocellular carcinoma detected after interferon therapy for chronic hepatitis C.

A. Tamori, T. Kuroki, K. Hirohashi, 2000, Hepato-gastroenterology.

Sildenafil-Induced Severe Cholestatic Hepatotoxicity

A. Tamori, N. Kawada, M. Ominami, 2009, The American Journal of Gastroenterology.

Polyamine metabolism and recurrence after resection for hepatocellular carcinoma.

A. Tamori, H. Kinoshita, S. Kubo, 2004, Hepato-Gastroenterology.

Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma

K. Iwaisako, T. Ochiya, A. Tamori, 2015, Scientific Reports.

Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome.

A. Tamori, N. Kawada, H. Fujii, 2012, Hepato-gastroenterology.

Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma

A. Tamori, S. Kubo, S. Nishiguchi, 2001 .

Treatment of hepatocellular carcinoma with use of microwave coagulation under laparoscopy

A. Tamori, S. Seki, T. Kuroki, 1997 .

Platelet‐associated IgG for the diagnosis of immune thrombocytopaenic purpura during peginterferon α and ribavirin treatment for chronic hepatitis C

A. Tamori, T. Yamane, M. Hino, 2008, Liver international (Print).

ITPA polymorphism correlates with the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy

A. Tamori, A. Hagihara, N. Kawada, 2017 .

Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2017, Scientific Reports.

Effects of alanine in patients with advanced primary biliary cirrhosis: preliminary report.

A. Tamori, H. Kinoshita, S. Kubo, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct‐acting antiviral therapy

A. Tamori, J. Tani, M. Sugiyama, 2018, Journal of viral hepatitis.

Meshwork pattern is an important risk factor for development of hepatocellular carcinoma in patients with HBV-related chronic hepatitis and cirrhosis.

A. Tamori, S. Seki, S. Nishiguchi, 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

M. Kudo, N. Hayashi, N. Hiramatsu, 2010, Hepatology research : the official journal of the Japan Society of Hepatology.

High prevalence of hepatitis C virus infection in Airin district, Osaka, Japan: A hospital‐based study of 1162 patients

A. Tamori, Y. Fujiwara, T. Arakawa, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis

A. Tamori, S. Kubo, M. Kuroda, 2013, BMC Cancer.

Phosphorylated Smad2 and Smad3 signaling: Shifting between tumor suppression and fibro‐carcinogenesis in chronic hepatitis C

S. Dooley, K. Tsuneyama, M. Sata, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response.

A. Tamori, H. Toyoda, E. Ogawa, 2024, Alimentary pharmacology & therapeutics.

Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis

A. Tamori, N. Kawada, S. Higashiyama, 2018, Medicine.

Sofosbuvir–velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan

K. Chayama, A. Tamori, N. Izumi, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.